Skip to main content
SpringerLink
Log in

CADScor System may save costs as a first-line 'rule out' test in the diagnosis of CAD in England

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Javanbakht M, et al. Economic Analysis of the CADScor System for Ruling Out Coronary Artery Disease in England. PharmacoEconomics-Open : 2 Sep 2021. Available from: URL: https://doi.org/10.1007/s41669-021-00297-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CADScor System may save costs as a first-line 'rule out' test in the diagnosis of CAD in England. PharmacoEcon Outcomes News 887, 9 (2021). https://doi.org/10.1007/s40274-021-08025-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08025-2

Search

Navigation